Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior funding notice (lapse in government funding) and the older Revision: v3.4.1 from the page.SummaryDifference0.7%

- Check11 days agoChange DetectedAdded a government funding status notice to the page. Updated the version history to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.7%

- Check18 days agoChange DetectedUI updates to the Record History page include a glossary toggle and color-coded highlights for changes (green for additions, red for deletions) with a new revision label (v3.4.0). Older No FEAR Act data and the revision label (v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check32 days agoChange DetectedRevision history now shows a new revision label v3.3.4 and removes the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.3.3 to the page and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows an added Revision: v3.3.2 and a removed Revision: v3.2.0, indicating a backend or UI version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.